New Delhi, March 24 To ensure ethical pharmaceutical practices in the supply chain of weight-loss drugs of the GLP-1 class, the Drugs Controller General of India (DCGI) has intensified its regulatory surveillance against the unauthorized sale and promotion of the medications.To this end...
New Delhi, March 11 The apex drug regulator, CDSCO, has issued an advisory, directing that weight-loss drugs, specifically GLP-1 medications, must only be sold with a prescription from a registered medical practitioner.It cautioned pharmaceutical companies against "directly or indirectly"...